Detailed explanation of the side effects of upadatinib extended-release tablets: how to prevent and treat them

Upadacitinib, as a selective Janus kinase (JAK) inhibitor, is mainly used to treat moderately to severely active rheumatoid arthritis (RA) and other immune-mediated diseases. Although upadatinib is effective in controlling inflammation and improving patient symptoms, its side effects also require sufficient attention.

Common side effects include an increased risk of infections, especially respiratory infections, shingles, and urinary tract infections, which are related to its suppression of immune system function. Abnormal liver function is also the focus of monitoring for patients, manifested by elevated transaminases. In addition, some patients may develop dyslipidemia, and cytopenias such as anemia, leukopenia, and thrombocytopenia have also been reported. Digestive system reactions such as nausea and diarrhea are also common.

In order to prevent these side effects, it is clinically recommended that patients undergo a comprehensive health assessment before using upadacitinib, including infection screening (such as tuberculosis), liver and kidney function and routine blood tests. During the treatment process, it is necessary to regularly monitor hematological indicators and liver function, and adjust the dose or suspend medication if abnormalities are detected early. For the prevention and treatment of infection, patients should avoid contact with sources of infection and seek medical treatment promptly when symptoms such as fever and cough occur. Some side effects, such as increased blood lipids, can be controlled by adjusting diet and using lipid-lowering drugs.

If severe hepatotoxicity or bone marrow suppression occurs, the drug must be stopped immediately and corresponding supportive treatment must be given. Patient education is also important to ensure that they understand the manifestations and management of side effects, which can help improve treatment safety and compliance.

In short, although the side effects of upadatinib cannot be ignored, through scientific monitoring and reasonable management, most patients can safely complete the treatment and enjoy the clinical benefits it brings.

Reference materials:https://www.rinvoq.com/